Co‐operative functions between nuclear factors NFκB and CCAT/enhancer‐binding protein‐β (C/EBP‐β) regulate the IL‐6 promoter in autocrine human prostate cancer cells
Weihua Xiao(University of Science and Technology of China), William L. Farrar(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), David R. Hodge(Pew Research Center), Xiaoyi Yang(Science Applications International Corporation (United States)), Lihua Wang(Jiangxi University of Traditional Chinese Medicine), Xiaohu Zhang(Soochow University)
Cited by 83
Related Papers
Thymoma production of T cell growth factor (Interleukin 2).
|The Journal of Immunology|1980|482
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422
Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers
|Nucleic Acids Research|2015|386
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
|Cancer Discovery|2017|336
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
|Science Translational Medicine|2019|259